Current research shows that endometrial cancer expresses more TIMPs (Tissue Inhibitors of Metalloproteinases), including MMP26 (Matrix Metalloproteinase 26), TIMP-3 (Tissue Inhibitor of Metalloproteinases-3), and TIMP-4(Tissue Inhibitor of Metalloproteinases-4) [37]. Here, MMP26 is linked to endometrial cancer.